Eosinophilia: Difference between revisions

 
(2 intermediate revisions by the same user not shown)
Line 10: Line 10:
*[[DRESS syndrome]], drug-induced
*[[DRESS syndrome]], drug-induced
*[[Parasitic infection]]
*[[Parasitic infection]]
*[[Coccidioidomycosis]] and other fungal infections
*[[Coccidioidomycosis]] and other [[fungal infections]]
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
Line 19: Line 19:


==Evaluation==
==Evaluation==
*CBC with differential


==Management==
==Management==
*Directed at underlying cause


==Disposition==
==Disposition==

Latest revision as of 17:04, 12 January 2022

Background

  • Defined usually as peripheral eosinophil count >0.5 x 109/L
  • Eosinophils normally comprise <7% of total WBC count

Clinical Features

Differential Diagnosis

Evaluation

  • CBC with differential

Management

  • Directed at underlying cause

Disposition

See Also

External Links

References